Tenet Healthcare Corporation vs Wynn Resorts, Limited — how do they compare? Tenet Healthcare Corporation trades at $267.21 (market cap $20.89B), while Wynn Resorts, Limited trades at $103.25 (market cap $10.79B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Wynn Resorts, Limited pays a 0.95% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals.
| THC | WYNN | |
|---|---|---|
Market Cap | $20.89B | $10.79B |
Sector | Health | Consumer Cyclical |
52-Week High | $262.63 | $133.34 |
52-Week Low | $161.37 | $94.37 |
Enterprise Value | $31.97B | $21.03B |
Dividend Yield | — | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Tenet Healthcare (THC) trades at $266.79, up 2.64% today, with strong technical momentum indicated by a golden cross and bullish moving averages. The stock shows robust fundamentals with a P/E of 10.03, net income margin of 9.9%, and consistent earnings beats in recent quarters. Recent news highlights Zacks' Strong Buy rating and positive Q2 2026 results, with revenue growth and raised 2026 outlook driving investor optimism.
The outlook remains positive given analyst consensus of a $281.44 price target and 81% buy ratings, though risks include policy headwinds and net cash outflows. Earnings growth and ambulatory segment strength present opportunities, but investors should monitor expense management and regulatory changes that could impact margins.
Wynn Resorts (WYNN) trades at $103.51, up 0.99% today, showing steady recovery from pandemic lows. The stock maintains bullish technical signals with strong institutional support, though faces headwinds from high debt levels and margin pressure. Recent Q2 2026 earnings beat expectations with $1.24 EPS versus $0.99 estimate, driven by Macau strength, while Las Vegas operations show slower growth. Analyst consensus remains strongly bullish with 64% buy ratings and $133 price target, representing 28% upside potential.
Investment outlook balances growth potential against significant risks. The company's Macau recovery and UAE expansion provide growth catalysts, but high leverage ($10.5B debt) and rising capex for Wynn Al Marjan project create cash flow pressure. Current valuation at 25x P/E appears reasonable given recovery trajectory, but investors should monitor margin trends and capital expenditure discipline closely given the negative shareholder equity position.
Trailing returns across standard periods
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →Wynn Resorts operates luxury casinos and resorts. The company was founded in 2002 by Steve Wynn, the former CEO. The company operates four megaresorts: Wynn Macau and Encore in Macao and Wynn Las Vegas and Encore in Las Vegas. Cotai Palace opened in August 2016 in Macao, Encore Boston Harbor in Massachusetts opened June 2019. Additionally, we expect the company to begin construction on a new building next to its existing Macao Palace resort in 2023, which we forecast to open in 2026. The company also operates Wynn Interactive, a digital sports betting and iGaming platform. The company received 76% and 24% of its 2019 prepandemic EBITDA from Macao and Las Vegas, respectively.
Read more on WYNN →